Ronald Blue Trust, Inc. Pacific Biosciences Of California, Inc. Transaction History
Ronald Blue Trust, Inc.
- $7.98 Billion
- Q3 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 1,033 shares of PACB stock, worth $1,921. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,033
Previous 4,087
74.72%
Holding current value
$1,921
Previous $5,000
80.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PACB
# of Institutions
252Shares Held
227MCall Options Held
656KPut Options Held
939K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.4MShares$62.1 Million0.54% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$43.9 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$43.5 Million6.35% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V820.3MShares$37.8 Million0.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$32.8 Million0.0% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $418M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...